Risk for Gastrointestinal Bleeding With Dabigatran, Rivaroxaban, and Warfarin
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Comparative Risk of Gastrointestinal Bleeding With Dabigatran, Rivaroxaban, and Warfarin: Population Based Cohort Study
BMJ 2015 Apr 24;350(xx)350:h1857, NS Abraham, S Singh, GC Alexander, H Heien, LR Haas, W Crown, ND ShahFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.